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Introduction
Metallo-b-lactamases (MBLs) belong to class B of the
b-lactamases [1–3]. All MBLs exhibit the ab ⁄ba sand-
wich fold [4] and unlike the enzymes of other classes
(A, C and D), which all contain a nucleophilic serine
residue in their active site, the MBLs utilize zinc to
perform hydrolysis [5,6]. The heterogeneous class of
MBLs is further divided into three groups (B1, B2 and
B3) according to substrate speciﬁcity and sequence
similarity [7]. Subclass B2 has a narrow substrate spec-
trum limited to carbapenems [8], whereas subclasses
B1 and B3 have broad substrate spectra, with B3
showing preferential activity for cephalosporins [9,10].
Subclass B1 contains IMP and VIM variants, as well
as NDM-1, which are encoded by mobile genetic ele-
ments, posing the greatest threat of all the MBLs. Also
present in the group are the well-characterized MBLs
of Bacillus cereus (BcII), which was the ﬁrst to be dis-
covered [11], and Bacteroides fragilis (CcrA) [12]. Sub-
class B2 contains the very similar Aeromonas enzymes,
CphA [13] and ImiS [14].
Subclass B3 consists of the L1 [15], FEZ-1 [16],
GOB-type enzymes [17,18], Thin-B [19], CAU-1 [20],
Mbl1b [21], BJP-1 [22] and CAR-1 [23]. However, only
the ﬁrst three are clinically relevant. L1 exhibits the
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The metallo-b-lactamase (MBL) GOB-1 was expressed via a T7 expression
system in Escherichia coli BL21(DE3). The MBL was puriﬁed to homoge-
neity and shown to exhibit a broad substrate proﬁle, hydrolyzing all the
tested b-lactam compounds efﬁciently. The GOB enzymes are unique
among MBLs due to the presence of a glutamine residue at position 116, a
zinc-binding residue in all known class B1 and B3 MBL structures. Here
we produced and studied the Q116A, Q116N and Q116H mutants. The
substrate proﬁles were similar for each mutant, but with signiﬁcantly
reduced activity compared with that of the wild-type. In contrast to the
Q116H enzyme, which bound two zinc ions just like the wild-type, only
one zinc ion is present in Q116A and Q116N. These results suggest that
the Q116 residue plays a role in the binding of the zinc ion in the QHH
site.
Abbreviations
ICP, inductively coupled plasma; IPTG, isopropyl b-D-1-thiogalactopyranoside; LB, Luria–Bertani; MBL, metallo-b-lactamase; TB, terrific broth.
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broadest substrate range of the MBLs and is uniquely
tetrameric [9,24,25]. FEZ-1 shares 29.7% sequence
identity with L1, but has a more limited substrate pro-
ﬁle, with a strong preference for cephalosporins
[16,26]. GOB-type enzymes include 18 variants, includ-
ing GOB-1, the ﬁrst isolated GOB enzyme [17]. GOB-1
is from Elizabethkingia meningoseptica (formerly Chry-
seobacterium meningosepticum), the pathogen responsi-
ble for neonatal meningitis, and also found to attack
immunocompromised patients. It shares sequence iden-
tities of 28% with L1 and 43% with FEZ-1 (computa-
tion performed at the SIB using the BLAST network
service). The GOB-18 variant studied by Moran-Barrio
et al. [18] differs from GOB-1 by just three residues,
Phe94, Ala137 and Asp282, far from the active site.
The three subclasses of MBLs also differ in their
zinc dependency [7]. Subclass B1 enzymes can be active
with one or two zinc ions in their active sites, whereas
those of subclass B3 contain two zinc ions [27,28]. In
contrast, subclass B2 enzymes are active with one zinc
ion and are inhibited by the binding of a second zinc
[29]. The crystal structures of the MBLs highlight two
sites of zinc co-ordination. The ﬁrst zinc site in classes
B1 and B3 (HHH) is composed of residues His116,
His118 and His196. The sole exceptions to this are the
GOB enzymes, which have a glutamine at position
116. In subclass B2, position 116 is occupied by an
asparagine residue [7] and this was previously thought
to be one of the residues to which the inhibitory zinc
binds. However, the recent structure of the subclass B2
CphA showed that the second inhibitory zinc ion was
just bound to the two remaining histidines, His196 and
His118 [30]. The second zinc site of subclass B1 is
identical to the ﬁrst site of subclass B2 and consists of
Asp120, Cys221 and His 263 (DCH), whereas in sub-
class B3, Cys221 is replaced by His121 (DHH) as a
zinc ligand [7,15,26].
Even though the GOB enzymes appear to have only
one intact zinc-binding site, they were placed in sub-
class B3 on the basis of their amino acid sequences
[17]. However, unlike L1 [24] they are monomeric and
unlike FEZ-1 [18] show no preference for cephalospo-
rins [17]. The crystal structures of both L1 and FEZ-1
have been published [15,26], whereas the structure of a
GOB-type enzyme has yet to be solved. Recent work
by Moran-Barrio et al. [18] suggests that the active
form of the enzyme contains only one zinc ion, located
in the DHH site. This is in contrast to all known B1
and B3 MBLs, with the possible exception of the
mono-Co++ form of BcII [31]. In the work described
here, we produced the GOB-1 MBL in Escherichia coli
from a T7-based expression vector. The results pre-
sented herein provide evidence for the presence of two
zinc ions in the enzyme as puriﬁed. Therefore, in con-
trast to the GOB-18 variant [18], denaturing and
refolding in the presence of zinc was not required.
Although the outcome of the kinetic study, performed
in the presence and absence of additional zinc, varied
with the replacing residue, each Gln116 mutant
showed a signiﬁcant decrease in activity when com-
pared with the wild-type enzyme.
Results
Construction of expression vector and
preliminary expression experiments
The pGB1 expression vector was constructed to include
the enzyme’s own signal peptide and stop codon. The
preliminary expression trials showed that the best yield
was obtained in terriﬁc broth (TB) medium in the
absence of isopropyl b-d-1-thiogalactopyranoside
(IPTG) with incubation at 28 C for 24 h and showed
no noticeable expression of the unprocessed precursor
species. Under these conditions, GOB-1 represented
only a low percentage of cell protein, but signiﬁcantly
more than with the pBS3 plasmid, previously described
in Bellais et al. [17]. Unfortunately, with the crude
extracts derived from the expression trials, activation
by the substrate was observed, which made quantiﬁca-
tion difﬁcult. This prevented an accurate determination
of the quantity of GOB-1 present in the crude extract,
but an estimate using the highest rate suggested that
40 mg of GOB-1 was produced per litre of culture.
Purification of wild-type GOB-1
The reported puriﬁcations of several MBLs utilize an
S-Sepharose column as the ﬁrst puriﬁcation step.
When applied to GOB-1, this step yielded an enzyme
with few contaminants. The second step was an UNO
S12 column and allowed the removal of some impu-
rity, but was not sufﬁcient to reach homogeneity. A
further puriﬁcation step on a molecular sieve removed
the two remaining contaminants of lower molecular
masses. After the three puriﬁcation steps, 7.6 mg of
GOB-1 were produced, showing no contaminants by
SDS ⁄PAGE. The use of the molecular sieve column
also conﬁrmed a 30 kDa molecular mass and thus a
monomeric structure, as shown by Bellais et al. [17].
MS and N-terminal sequencing of wild-type
GOB-1
The ESI-TOF MS spectra of the denatured protein
(data not shown) showed two peaks, indicating the
L. E. Horsfall et al. Metallo-b-lactamase GOB-1
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presence of two proteins separated by 299 Da. The
native ESI-TOF MS spectra (Fig. 1) also showed two
peaks separated by 300 Da. This showed the presence
of two proteins that could not be separated during
puriﬁcation and by SDS ⁄PAGE and that contained
the same amount of zinc. This implied that both pro-
teins were GOB-1, although one was modiﬁed in some
way, probably by incorrect cleavage of the signal pep-
tide to create b-lactamase ragged ends.
The mass difference between the native and dena-
tured spectra corresponds to the mass of zinc in the
enzyme (Table 1). The result suggests that the native
protein contains two zinc ions per wild-type molecule.
The other members of subclass B3, both L1 and FEZ-
1, also contain two zinc ions in their active sites [9,10].
To verify the hypothesis that GOB-1 has ragged
ends (not a unique phenomenon with respect to MBLs
[32]), the N-terminus of the enzyme was sequenced.
The presence of two N-terminal sequences QVVKE
and LNAQV conﬁrmed that the signal peptide was
cleaved at two positions.
In addition, a sample was digested using trypsin and
the molecular mass of the resulting peptides was mea-
sured by MALDI-TOF MS (Fig. 2). A theoretical diges-
tion of GOB-1 was performed using Peptide Mass on
the expasy.org website. The sequence coverage given by
the peptides produced by the tryptic digestion of GOB-1
is shown in Fig. S1. All the peaks detected by MALDI-
TOF MS could be identiﬁed as peptides produced by
the tryptic digestion, with three exceptions. The peak at
1598 (Fig. 2) is not a theoretical product of digestion. It
does, however, correspond to the mass of the N-termi-
nal peptide (1299 kDa) plus 298 Da, a value that in turn
corresponds to the mass of the last three amino acids of
the signal peptide, LNA. Another of the unidentiﬁed
peptides, of mass 1282, is the mass of the N-terminal
peptide less 17 Da, suggesting that the N-terminal gluta-
mine residue has undergone cyclization into pyro-gluta-
mate with the loss of NH3. The third peak at 1453 kDa
could not be explained and does not correspond to
digestion of the enzyme or unprocessed precursor species.
Mutation of the Gln116 residue
At position 116, GOB-1 has a glutamine rather than a
histidine residue like other members of subclass B3 (or
indeed subclass B1). To investigate the effect of this
residue it was mutated to histidine, asparagine (the
amino acid at position 116 in subclass B2) and, as a
control, alanine, giving the Q116H, Q116N and
Q116A mutants, respectively.
The best puriﬁcation method found for the mutant
enzymes was to use the S-Sepharose column, followed
by a 5 mL Econo-Pac CHT-II cartridge. The remaining
Fig. 1. ESI-TOF MS of wild-type GOB-1
showing the presence of two protein peaks
separated by 300 Da.
Table 1. Masses of the wild-type and mutant enzymes measured
by ESI-TOF MS and calculated from their amino acid sequences.
The calculated difference between measured masses of the dena-
tured and native wild-type and mutant enzymes corresponds to the
mass of zinc present in the enzyme.
GOB-1 enzyme Calculated Denatured Native Difference
Wild-type 31196.5 31195.5 31321 125.5
Q116A 31139.0 31138.5 31202 63.5
Q116N 31182.0 31183.0 31243 60.0
Q116H 31205.5 31206.0 31331 125.0
Metallo-b-lactamase GOB-1 L. E. Horsfall et al.
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impurities were removed in a third puriﬁcation step on
an S-Source column. This last step produced two elu-
tion peaks for each enzyme. In each case, the mass dif-
ference between the two elution peaks was found to be
18 Da by ESI-TOF MS (Fig. 3) and the highest peak
corresponded to the theoretically calculated mass. As a
consequence, the N-terminal residue of the mutants has
undergone partial cyclization. The protein of highest
molecular mass (Table 1) was used in all experiments.
MS of GOB-1 mutants
Native ESI-TOF MS spectra of the mutants were
obtained. Although Fig. 4 reveals the presence of
many salt peaks, the spectra suggest that both Q116N
and Q116A contain one zinc ion per molecule. This
was conﬁrmed by the inductively coupled plasma
(ICP) ⁄MS results (see below). Therefore, the mutation
of the glutamine residue at position 116 results in the
loss of zinc from the corresponding site of the enzyme
under MS conditions. Q116H, like the wild-type, con-
tains two zinc ions (Tables 1, 2).
Determination of the zinc and iron contents
using ICP ⁄MS
In contrast to the wild-type and Q116H enzymes,
ICP ⁄MS failed to highlight the binding of two zinc
ions by the Q116A and Q116N enzymes (Table 2).
Moreover, the ICP ⁄MS discarded the presence of
bound iron in all the enzymes.
Kinetic study
Before the kinetic characterization of GOB-1, the opti-
mum concentration of ZnCl2 in the buffer was deter-
mined. At the three concentrations of imipenem tested,
the addition of Zn2+ in the buffer did not signiﬁcantly
modify the activity. However, 50 lm ZnCl2 gave a
slightly higher rate of hydrolysis. Consequently, 50 lm
ZnCl2 was thereafter added to the buffer.
The steady-state kinetic parameters of the wild-type
and mutant GOB-1 enzymes were measured with the
b-lactam substrates benzylpenicillin, cefoxitin, cephalo-
thin, imipenem, meropenem and nitroceﬁn, both in the
Fig. 2. Peptide mass fingerprint of GOB-1
digested by trypsin for 4 h (inset: N-termi-
nus modified peptide with mass accuracy of
10 p.p.m.).
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Fig. 3. Superimposed ESI-TOF MS of the
two active peaks produced during the final
step of purification of the Q116H mutant.
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presence and the absence of added zinc. The results
are shown in Table 3. The wild-type enzyme hydroly-
sed all the substrates very efﬁciently, almost indepen-
dently of the zinc concentration in the buffer, showing
no strong preference for any type of b-lactam. Our
results support those previously reported for GOB-1
[17], with the enzyme showing the highest rate of sub-
strate turnover with penicillin (kcat 630 s
)1) and the
highest kcat ⁄KM value with meropenem (8.0 lm)1Æs)1).
The mutations of Gln116 signiﬁcantly affected the
catalytic ability of the enzyme, as would be expected for
a zinc-binding residue. In the absence of added zinc, the
activity was decreased 60–600-fold when the residue was
mutated to the nonchelating alanine (Q116A). However,
the resulting enzyme was not completely inactive and
although the kcat values were dramatically decreased,
the Km values were very similar. Activity was not
restored by the addition of 50 lm zinc. Indeed, although
kcat values slightly increased (e.g. 4.6-fold for imipe-
nem), the kcat ⁄Km values slightly decreased due to the
large increase in KM values (34-fold for imipenem).
The effects of the Q116N mutation were slightly dif-
ferent. The results in Table 2 show an important loss
of activity in the absence of zinc (160–1500 times),
mainly due to a decrease in kcat values. The KM values
remained quite similar (meropenem, cefoxitin), slightly
(imipenem, benzylpenicillin) or signiﬁcantly increased
(nitroceﬁn, cephalothin). In contrast to the Q116A
mutant, the activity of the Q116N mutant increased
when 50 lm zinc was present in the buffer (Q116N is
then only 1.3–110-fold less active than the wild-type).
KM values were similar to that of the wild-type (with
the exception of nitroceﬁn). Initial hydrolysis rates of
100 lm nitroceﬁn were measured in the presence of
increasing zinc concentrations (0, 1, 2.5, 5, 10, 25, 50,
100, 250, 500 and 1000 lm). This experiment showed
that the maximal rate is obtained at a 50 lm zinc con-
centration and is constant up to the highest tested con-
centration. The apparent dissociation constant for the
second zinc ion (KD2) determined from this graph was
2.5 ± 0.3 lm (Fig. S2).
The effects of the Q116H mutation were less drastic.
The activity decrease in comparison with the wild-type
enzyme was only 2.1–74-fold. The kcat values decreased
only 1.9- (for benzylpenicillin) to 50-fold (for imipe-
nem). The KM values signiﬁcantly increased for all the
substrates but meropenem and cefoxitin. Q116H showed
similar kcat and KM values in the presence of 50 lm zinc.
Apo-GOB-1 and the remetallated form
The GOB-1 apoprotein was devoid of b-lactamase
activity that could be recovered by the addition of
Zn(II). Remetallated GOB-1 bound 2 equivalents of
zinc, as shown by ICP ⁄MS and MS (Fig. S3). How-
ever, its activity was only 60% of that of the enzyme
as isolated. The addition of zinc (50 lm, 100 lm or
1 mm) to the reaction medium did not signiﬁcantly
modify this activity.
Table 2. Summary of zinc binding for wild-type and mutants GOB-
1. Standard deviation values were below 10%.
Protein
Zn2+ content in a buffer containing
less than 0.4 lM of free zinc
MS ICP ⁄MS
Wild-type 2 2.0
Q116A 1 0.8
Q116N 1 0.9
Q116H 2 2.0
Fig. 4. Native ESI-TOF MS of the wild-type
and mutant GOB-1.
Metallo-b-lactamase GOB-1 L. E. Horsfall et al.
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Inactivation by metal chelator
EDTA inactivated GOB-1 and its mutants in a time-
dependent manner. The ki was independent of chelator
concentration for the wild-type and mutant enzymes
(Fig. S4). This suggests that EDTA acts by scavenging
the free metal, with the ki value representing the rate
of zinc dissociation from the enzyme. The ki value of
wild-type GOB-1 was measured in the concentration
range 0.5–50 lm, similar to those used to inactivate
the other B3 enzymes L1 [24] and FEZ-1 [10] (up to
200 lm and 0.5–10 lm, respectively), indicating ki val-
ues of 0.0053 s)1. This result is not very different
from that obtained with FEZ-1 (0.025 s)1) [10]. By
comparison, incubation of IMP-1 (subclass B1) with
10 mm EDTA for 1 h only inactivated the enzyme by
10% [33]. The mutants behaved in a similar manner
and the following ki values were obtained: Q116A,
0.0044 s)1; Q116H, 0.0068 s)1 and Q116N 0.011 s)1.
In the cases of the di-zinc species (i.e. the wild-type
and Q116H), these rather similar apparent ki values
might correspond to the loss of the most tightly bound
Zn++.
Discussion
The MBL GOB-1 is a very efﬁcient enzyme that
hydrolyses the six tested b-lactams with kcat ⁄KM values
above 106 m)1Æs)1. All the kcat ⁄KM values reported
here are slightly higher (between 1.5- and 10-fold) than
those previously published by Bellais et al. [17], proba-
bly because of the higher protein purity. The kinetic
parameters determined here for the GOB-1 enzyme are
also similar to those previously determined for the
GOB-18 variant [18].
The mutants of GOB-1 generated by site-directed
mutagenesis of Gln116 exhibit a loss of activity that
cannot be corrected by the addition of zinc. The
Q116H mutant and the wild-type enzyme both contain
two zinc ions in the active site and therefore show little
difference upon the addition of further zinc. However,
the mutant exhibited signiﬁcantly less activity than the
Table 3. The steady-state kinetic parameters for the GOB-1 wild-type and mutants Q116A, Q116N and Q116H, both in the presence and in
the absence of added 50 lM ZnCl2.
50 lM zinc No added zinc
KM (lM) kcat (s
)1)
kcat ⁄ KM
(lM–1Æs)1) KM (lM) kcat (s
)1)
kcat ⁄ KM
(lM)1Æs)1)
Wild-type
Imipenem 13 ± 1 85 ± 2 6.5 18 ± 0.6 77 ± 2 4.2
Meropenem 22 ± 1 170 ± 3 8.0 29 ± 1 100 ± 7 3.5
Benzylpenicillin 190 ± 10 630 ± 10 3.4 130 ± 6 540 ± 7 4.2
Nitrocefin 16 ± 3 14 ± 0.5 0.87 7.1 ± 0.2 20 ± 2 2.8
Cephalothin 7.9 ± 0.5 32 ± 0.4 4.0 3.8 ± 0.1 24 ± 0.7 6.5
Cefoxitin 8.9 ± 1 9.6 ± 0.4 1.1 1.4 ± 0.04 3.5 ± 0.3 2.6
Q116A
Imipenem 720 ± 100 2.3 ± 0.2 0.0032 21 ± 0.9 0.50 ± 0.005 0.024
Meropenem 130 ± 20 1.1 ± 0.05 0.0088 34 ± 3 0.62 ± 0.02 0.018
Benzylpenicillin 410 ± 40 4.6 ± 0.1 0.011 96 ± 10 1.9 ± 0.08 0.020
Nitrocefin 30 ± 4 0.12 ± 0.002 0.0038 13 ± 1 0.080 ± 0.003 0.0062
Cephalothin 42 ± 4 0.61 ± 0.01 0.015 15 ± 0.7 0.16 ± 0.002 0.011
Cefoxitin 78 ± 10 0.21 ± 0.009 0.0027 7.2 ± 0.09 0.31 ± 0.01 0.043
Q116N
Imipenem 42 ± 4 3.8 ± 0.1 0.025 69 ± 6 0.95 ± 0.03 0.014
Meropenem 20 ± 2 1.5 ± 0.03 0.074 31 ± 3 0.44 ± 0.01 0.014
Benzylpenicillin 140 ± 10 22 ± 0.5 0.16 200 ± 10 4.9 ± 0.1 0.025
Nitrocefin 360 ± 60 11 ± 0.9 0.031 210 ± 40 0.86 ± 0.06 0.0041
Cephalothin 4.7 ± 0.1 1.2 ± 0.05 0.25 37 ± 4 0.16 ± 0.004 0.0044
Cefoxitin 10 ± 0.3 0.16 ± 0.01 0.016 2.3 ± 0.1 0.026 ± 0.003 0.011
Q116H
Imipenem 170 ± 20 21 ± 0.7 0.13 150 ± 10 17 ± 0.5 0.12
Meropenem 25 ± 3 2.3 ± 0.07 0.089 17 ± 2 2.0 ± 0.05 0.11
Benzylpenicillin 790 ± 40 300 ± 6 0.38 850 ± 60 280 ± 7 0.33
Nitrocefin 43 ± 6 3.5 ± 0.1 0.080 43 ± 4 1.6 ± 0.05 0.038
Cephalothin 64 ± 4 9.9 ± 0.2 0.15 57 ± 6 8.0 ± 0.3 0.14
Cefoxitin 1.8 ± 0.1 0.27 ± 0.03 0.15 2.5 ± 0.06 0.37 ± 0.03 0.15
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wild-type GOB-1 (kcat shows a two- to 50-fold
decrease, dependent upon which substrate is examined)
and increased Km values, suggesting than the steric
effect of the larger, less ﬂexible histidine residue hin-
ders the positioning of the substrates in the active site.
Another possibility would be the creation of a modi-
ﬁed zinc position in the recreated HHH site leading to
a decreased efﬁciency. However, as all other B1 and
B3 enzymes include a histidine at position 116, this will
remain speculation until the structure of the GOB-1
active site is directly determined.
In contrast to the Q116H mutant, the presence of an
alanine or an asparagine residue at position 116
decreased the ability of the latter mutants to chelate a
zinc ion in the AHH or NHH site. Indeed, in the
absence of added zinc ([Zn] < 0.5 lm), these mutants
were under a mono-zinc form, whereas the wild-type
GOB-1 is already in a di-zinc form. The Km values
determined in these conditions for the Q116A mutant
are very similar to those corresponding to the wild-type
enzyme. This suggests that the Q116A mutation, which
affects the metal content, does not affect the binding of
the substrates. A similar behaviour is observed for the
carbapenemase activity of the Q116N mutant.
This decreased ability to chelate a second zinc is also
reﬂected by the KD2 value determined for the Q116N
mutant. These results prove that Q116 plays a role in
the binding of the zinc ion in the QHH site. The kcat
and kcat ⁄Km values of the Q116A and Q116N mutants
were strongly decreased (kcat shows an 11–284-fold
decrease for Q116A and a 23–227-fold decrease for
Q116N compared with that of the wild-type) and can-
not be restored by the addition of zinc. Nevertheless,
the activity of the Q116N mutant increased with
increasing zinc concentration in the buffer. This con-
trasts with the subclass B2 enzymes, which also have
an asparagine residue at this position [7], as they are
inhibited upon binding of a second zinc ion. However,
it was demonstrated by Bebrone et al. [30] that this
inhibition results from immobilization of the catalyti-
cally important His118 and His196 residues.
Our results differ from those obtained for the GOB-
18 variant, which is supposed to be fully active with a
single zinc ion in the DHH zinc-binding site [18].
GOB-1 and GOB-18 enzymes only differ by three
point mutations apparently far from the active site
(Leu94Phe, Ala137Val and Asp282Asn), which makes
the difference in behaviour between these enzymes dif-
ﬁcult to explain. GOB-18 was overproduced as a
fusion to GST in the cytoplasm of E. coli and con-
tained signiﬁcant amounts of zinc and iron (0.45–0.75
iron ⁄GOB-18 and 0.01–0.20 zinc ⁄GOB-18). Only the
mono-zinc form of GOB-18 could be obtained by
remetallization of the apoprotein. Its activity largely
exceeded that of the GOB-18 enzyme as isolated and
the addition of zinc did not modify the kinetic parame-
ters [18]. Further work by the same authors showed
the periplasmic enzyme to contain only zinc ions,
but the number remained unmeasured [18,34]. In con-
trast, the protocol of production and puriﬁcation
described here, which uses the enzyme’s own signal
peptide, produces GOB-1 as a fully active di-zinc
enzyme. We have also shown that it is possible to
reconstitute a binuclear GOB-1 from the metal-depleted
enzyme by using a similar procedure to that previously
described [18]. Furthermore, the Q116A and Q116N
mutants that had lost the zinc in the QHH site showed
a signiﬁcantly decreased activity compared with that of
the wild-type enzyme; the difference in both kcat and
the zinc content can only be accounted for by a single
amino acid change if this is a zinc-binding residue.
GOB-1 is not a hybrid between subclasses B2 and
B3, as previously suggested (Garau et al. [35]), but
rather a new subclass B3 enzyme using a slightly smal-
ler, more ﬂexible, chelating residue. Surprisingly, this
glutamine residue does not seem to be detrimental to
the activity of the GOB enzymes when compared with
the enzymes with a conventional HHH site.
Materials and methods
Chemicals
Buffers and BSA were purchased from BDH Chemicals
(Poole, UK) or Sigma-Aldrich (Steinheim, Germany); IPTG
from Eurogentech (Lie`ge, Belgium) and kanamycin, dimeth-
ylsulfoxide and ZnCl2 from Merck (Darmstadt, Germany).
Meropenem (De300 = )6500 m
)1Æcm)1) was a gift from ICI
Pharmaceuticals (Macclesﬁeld, UK). Imipenem (De300 =
)9000 m)1Æcm)1) was a gift from Merck Sharpe and Dohme
Research Laboratories (Rahway, NJ, USA). Benzylpenicillin
(De235 = )775 m
)1Æcm)1) was a gift from Rhoˆne-Poulenc
(Paris, France). Chloramphenicol, cefoxitin (De260 =
)6600 m)1Æcm)1), cephalothin (De273 = )6300 m
)1Æcm)1)
and EDTA were purchased from Sigma (St Louis, MO,
USA) and nitroceﬁn (De482 = 15 000 m
)1Æcm)1) from Uni-
path Oxoid (Basingstoke, UK). Sequencing grade modiﬁed
trypsin was obtained from Promega (Madison, WI, USA)
and a-cyano-4-hydroxycinnamic acid was from Aldrich
(Taufkirchen, Germany). The peptide standard mixture was
purchased from Applied Biosystems (Foster City, CA, USA).
Bacterial strains and vectors
The plasmid pBS3 has been described previously. Escheri-
chia coli DH5a was used as the host for recombinant plas-
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mids during the construction of the expression vectors. Esc-
herichia coli BL21-DE3 and E. coli BL21-DE3 (pLysS)
(Novagen, Madison, WI, USA) were both tested as the
hosts for the expression plasmids. The expression vector
pET28a (Novagen) was used for the construction of the
T7-based expression factor.
Construction of the expression vector and
preliminary expression experiments
BamH1 and Xho1 restriction sites were introduced at either
end of the blaGOB-1 gene by PCR using the oligonucleotide
primers (5¢-GGGGGGGGATCCATGAGAAATTTTGCTA
CACTGTTTTTCATG-3¢) and (5¢-CCCCCCCTCGAGTTA
TTTATCTTGGGAATCTTTTTTTATTTTGTC-3¢), where
the restriction sites generated are underlined. The PCR
conditions were: incubation at 95 C for 5 min; 30 cycles
of ampliﬁcation that involved denaturation for 1 min at
95 C, annealing for 1 min at 58 C and extension for 1 min
at 68 C; and 5 min at 68 C after the cycling. Pfu and taq
polymerase (Promega) were used for the PCR. The PCR
products were cloned into the pET28a vector to obtain
the recombinant plasmid pGB1, which was then trans-
formed into E. coli DH5a. The gene was sequenced to verify
that no unwanted mutations had taken place during the
PCR.
The pGB1 vector was transformed into E. coli BL21-
DE3 and BL21-DE3 (pLysS). Preliminary expression tri-
als involved single colonies of E. coli BL21-DE3 and
BL21-DE3 (pLysS) containing pGB1 used to inoculate
100 mL Luria–Bertani (LB), containing 50 lgÆmL)1 kana-
mycin. The cultures were incubated overnight at 37 C
with orbital shaking at 250 r.p.m. before 2 mL samples
were removed and added to 100 mL medium. Three types
of medium, 2XYT (16 gÆL)1 tryptone, 10 gÆL)1 yeast
extract, 5 gÆL)1 sodium chloride), TB and LB, supple-
mented with 50 lgÆmL)1 kanamycin were tested. After
selection of the best medium, additional conditions were
studied: two temperatures (28 and 37 C), when the cul-
ture reached an absorbance of 0.6 at 600 nm and three
different IPTG concentrations (0, 0.1 and 1 mm). Aliqu-
ots (2 mL) of the various cultures were sampled after 2,
4, 6, 24, 33 and 48 h. After centrifugation for 1 min at
15 000 g, the bacterial pellet was resuspended in 500 lL
buffer (Hepes; 20 mm at pH 6.5 containing 50 lm ZnCl2).
Cells were lysed by sonication on ice, which involved
5 · 15 s pulses with 30 s delays. The cell debris was
removed by centrifugation at 15 500 g for 10 min at
4 C. A 15 lL sample from each aliquot was analysed by
SDS ⁄PAGE.
The enzyme activity in each sample was determined by
following the hydrolysis of 100 lm imipenem at 300 nm in
20 mm Hepes at pH 6.5 containing 50 lm ZnCl2 using a
Uvikon XL spectrophotometer and 10 mm path length
cells.
Mutagenesis
The Quick Change site-directed mutagenesis kit (Strata-
gene, La Jolla, CA, USA) was used to perform the muta-
genesis on the pGB1 plasmid. The primers used for this
experiment were as follows:
For the Q116A mutant forward and reverse:
(5¢-GATCTTGCTGCTTACTGCGGCTCACTACGACC
ATACAGG-3¢)
(5¢-GCACCTGTATGGTCGTAGTGAGCCGCAGTAAG
CAGC-3¢)
For the Q116N mutant forward and reverse:
(5¢-GATCTTGCTGCTTACTAACGCTCACTACGACC
ATACAGG-3¢)
(5¢-GCACCTGTATGGTCGTAGTGAGCGTTAGTAAG
CAGC-3¢)
For the Q116H mutant forward and reverse:
(5¢-GATCTTGCTGCTTACTCATGCTCACTACGACC
ATACAGG-3¢)
(5¢-GCACCTGTATGGTCGTAGTGAGCATGAGTAA
GCAGC-3¢)
Production and purification of the zinc
b-lactamase
LB medium (100 mL) containing 50 lgÆmL)1 kanamycin
was inoculated with a colony of E. coli BL21-DE3 carrying
the pGB1 plasmid and incubated overnight at 37 C with
orbital shaking at 250 r.p.m. Twenty millilitres of preculture
were added to 2 L TB medium and incubated at 28 C for
24 h under orbital shaking. Cells were harvested by centrifu-
gation at 14 500 g for 20 min at 4 C. The pellet was resus-
pended in 200 mL buffer A (20 mm sodium cacodylate, pH
6.5) before the cells were disrupted (Basic Z model; Constant
Systems Ltd, Warwick, UK). Cell debris was removed by
centrifugation at 14 300 g for 40 min at 4 C and the super-
natant dialysed overnight against buffer A at 4 C. The
crude extract was then loaded on to an S-Sepharose FF col-
umn (2.6 · 34 cm; Pharmacia, Uppsala, Sweden) equili-
brated in buffer A. The column was washed with buffer A
before a salt gradient of 0–0.5 m NaCl in ﬁve column vol-
umes was used to elute the GOB-1 protein. The active frac-
tions were pooled and dialysed overnight against buffer A to
remove the salt. The sample was loaded on to an UNO S-12
column equilibrated with buffer A and eluted with a 0–0.5 m
NaCl gradient in ﬁve column volumes. The fractions that
showed b-lactamase activity were then loaded on to a Seph-
acryl-100 molecular sieve column (1.5 · 56 cm) previously
equilibrated in buffer B (buffer A with 0.25 m NaCl). For
molecular mass determination on this column, the following
proteins were used for calibration; BSA 66.2 kDa, ovalbu-
min 45 kDa, soybean trypsin inhibitor 21.5 kDa, lysozyme
14.4 kDa. Active fractions were pooled, dialysed against
buffer A and concentrated to a ﬁnal concentration of
approximately 1 mgÆmL)1, before being stored at )20 C.
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The mutant plasmids were transformed into E. coli
BL21-DE3 and production was carried out as described
above for the wild-type. Puriﬁcation was performed as
described for the wild-type with the following modiﬁca-
tions. The second column used was a 5 mL ceramic
hydroxyapatite Econo-Pac CHT-II cartridge (Bio-Rad,
Hercules, CA, USA). The puriﬁcation was carried out as
suggested in the manufacturer’s instructions). The third col-
umn, an S-Source column from Amersham Biosciences (Pis-
cataway, NJ, USA), was used to separate the desired
mutants from the variant of the enzyme with an N-terminal
pyro-glutamate residue. The enzyme was loaded and the
column was washed in 20 mm sodium cacodylate pH 6.5
before a salt gradient of 0–0.5 m NaCl in 10 column vol-
umes was used to elute the GOB-1 mutant.
MS and the determination of the N-terminal
sequence
Native or denatured intact enzyme
Enzyme samples were desalted using Microcon YM-10
(10 kDa) centrifugal ﬁlters (Millipore, Billerica, MA, USA)
in 15 mm ammonium acetate (pH 7.5). Seven dilution ⁄ con-
centration steps were performed at 4 C and 14 000 g. This
yielded a 100 lm stock enzyme solution in ammonium ace-
tate pH 7.5. The experimental samples were then prepared
by diluting the enzyme to a ﬁnal concentration of 15 lm in
15 mm ammonium acetate pH 7.5 directly in a 96-well
plate. ESI-MS analyses used a Q-TOF MS (Q-TOFmicro
Micromass, Altrincham, UK) interfaced with a NanoMate
chip-based nano-ESI source (Advion Biosciences, Ithaca,
NY, USA). Samples were infused into the Q-TOF through
the ESI chip (estimated ﬂow rate 100 nLÆmin)1). Typically,
a spraying voltage of 1.70 kV ± 0.1 kV, depending on the
‘sprayability’ of the sample, and a sample pressure of
0.25 psi were applied. The instrument was equipped with a
standard Z-spray source block. Clusters of Cs(n+1)In
(1 mgÆmL)1 CsI in 100% methanol) were used for calibra-
tion. Calibration and sample acquisitions were performed
in the positive ion mode in the range of m ⁄ z 500–5000.
Operating conditions for the MS were: sample cone voltage
50, 80 and 200 V, source temperature 40 C. Acquisition
and scan times were 20 and 1 s, respectively. The pressure
at the interface between the atmospheric source and the
high vacuum region was ﬁxed at 6.6 mbar (measured with
the roughing pump Pirani gauge) by throttling the pumping
line using an Edwards Speedivalve to provide collisional
cooling.
Peptide mapping
After denaturation at 100 C for 15 min, 10 lg of GOB-1
was digested with 0.5 lg trypsin in 50 mm NH4HCO3 (pH 8)
for 4 h at 37 C. The digestion was stopped by adding 0.1%
triﬂuoroacetic acid. Digested protein (10 lL) was loaded on
to a ZipTip C18 (Millipore). Elution was performed with a
10 lL matrix solution (a-cyano-4-hydroxycinnamic acid in
50% acetonitrile, 0.1% triﬂuoroacetic acid) on a MALDI
plate and dried before the MALDI measurement.
MS analysis was performed using a 4800 MALDI TOF ⁄
TOF analyser (Applied Biosystems ⁄MDS SCIEX)
equipped with a 200 Hz Nd:YAG-Laser (k = 355 nm,
3–7 ns pulse width). MS data were acquired in the positive
ion reﬂectron mode with 470 ns delayed extraction, accumu-
lating 500 laser shots using the 4000 Series explorer
remote access client software (version 3.5.1). External mass
calibration was performed in the mass range m ⁄ z of 800–
3500. The calibration mixture consisted of the following
compounds: des-Arg1-bradykinin [904.4681], angiotensin
I [1296.6853], Glu1-ﬁbrinopeptide B [1570.6774], adrenocor-
ticotropic hormone fragments 1–17 [2093.0867], adreno-
corticotropic hormone fragments 18–39 [2465.1989],
adrenocorticotropic hormone fragments 7–38 [3557.9294].
For MS ⁄MS measurements, the acceleration voltage was
8 kV, the laser energy 4090 and 4000 laser shots were accu-
mulated.
N-terminal sequence
The N-terminal sequence was determined using a gas-phase
sequencer (Prosite 492 protein sequencer; Applied Biosys-
tems).
Determination of the zinc and iron content using
ICP ⁄MS
Protein samples were dialysed against 20 mm sodium caco-
dylate, pH 6.5. Protein concentrations were then deter-
mined by standard colorimetric assays (BCA; Pierce,
Rockford, IL, USA). Zinc and iron concentrations were
measured by ICP MS at the Malvoz Institute (Province de
Lie`ge, Belgium). The metal ⁄ enzyme ratio was calculated
from the differences in metal concentration between the
enzyme sample and the dialysis buffer.
Determination of kinetic parameters
Hydrolysis of antibiotics by the wild-type and mutant
GOB-1 was monitored by following the variation in absor-
bance using a Uvikon 860 spectrophotometer connected to
a microcomputer via an RS232 serial interface or a Uvikon
XL spectrophotometer. Reactions were performed in ther-
mostatically controlled 10 and 2 mm path length cells at
30 C and using 20 mm sodium cacodylate buffer pH 6.5,
containing 20 lgÆmL)1 BSA (and 50 lm ZnCl2 when indi-
cated). The steady-state kinetic parameters were determined
under initial rate conditions using the Hanes linearization
of the Henri–Michaelis–Menten equation. Low KM values
were determined as Kis using meropenem as the reporter
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substrate. In these cases, the kcat values were obtained from
initial hydrolysis rates measured at saturating substrate
concentrations. All data were analysed using Microsoft
Excel and the kaleidagraph 3.5 programme [36].
Enzymatic measurement in the presence of
increasing concentrations of zinc and the
determination of KD2
Activity was measured in the presence of increasing concen-
trations of zinc at 30 C in 20 mm sodium cacodylate buffer
pH 6.5, containing 20 lgÆmL)1 BSA, as previously
described. The binding of the second zinc ion resulted in an
increase in activity and equation 1 was used:
RA ¼ ½ðKD2 þ a½ZnÞ=ð½Zn þ KD2Þ ð1Þ
where a represents the ratio of activity at saturating zinc
concentration versus activity in the absence of added zinc
(Act. [Zn](¥) ⁄Act. [Zn](0)).
Experimental data were ﬁtted to equation 1 by nonlinear
regression analysis with the help of the sigma plot soft-
ware.
Preparation of the GOB-1 apoenzyme and the
remetallated form
The GOB-1 apoprotein was prepared by treating 40 lm
enzyme samples in 10 mm Tris ⁄HCl, pH 7.0, with chelating
agents in mild denaturing conditions, as previously
described for GOB-18 [18]. The remetallated form was
obtained by dialysing the apo-GOB-1 against 100 volumes
of 10 mm Tris ⁄HCl, pH 7.0, 50 mm NaCl, with 40 lm
ZnSO4.
Inactivation by chelating agents
The inactivation of wild-type and mutant GOB-1 by the
chelating agent EDTA was followed using imipenem as a
reporter substrate and measuring the initial rates of hydro-
lysis at varying EDTA concentrations (0.5–50 lm), in the
same buffer as that used for the other kinetic experiments,
without the addition of zinc. The dependence of ki on the
concentration of chelating agent was investigated.
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